HLA-A*1101 & B2M & WT1 (FSCRWPSCQK)

HLA-A*1101 & B2M & WT1 (FSCRWPSCQK) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    AF647 Labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HLW-HA2H4
Human
HEK293
Alexa Fluor™ 647-Labeled Human HLA-A*11:01&B2M&WT-1 (FSCRWPSCQK) Tetramer Protein
Total: 1
  • 1

HLA-A*1101 & B2M & WT1 (FSCRWPSCQK) Background

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*1101 WT1 (FSCRWPSCQK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and FSCRWPSCQK peptide of the KRAS.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
GT-02287GT-02287Phase 1 ClinicalGain Therapeutics IncParkinson Disease
Details
VQ-101VQ-101Phase 1 ClinicalVanqua Bio IncParkinson Disease
Details
  • Product List
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8